Down-regulation of lipocalin 2 contributes to chemoresistance in glioblastoma cells

Journal of Neurochemistry

Volumn 111, Issue 5, 2009, Pages 1238-1251

  Zheng, Long Tai ^a   Lee, Shinrye ^a   Yin, Guo Nan ^a   Mori, Kiyoshi ^b   Suk, Kyoungho ^a  

^a Kyungpook National University School of Medicine   (South Korea)

^b KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Apoptosis; BCNU; Chemoresistance; Glioma; Lcn2

Indexed keywords

CARMUSTINE; CISPLATIN; COMPLEMENTARY DNA; DNA; ETOPOSIDE; GLIAL FIBRILLARY ACIDIC PROTEIN; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; MULTIDRUG RESISTANCE PROTEIN 1; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BRAIN TUMOR; CANCER CHEMOTHERAPY; CELL CYCLE ARREST; CELL DEATH; CONTROLLED STUDY; DEPHOSPHORYLATION; DNA CONTENT; DNA DETERMINATION; DOWN REGULATION; GENETIC TRANSFECTION; GENETIC VARIABILITY; GLIOBLASTOMA; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL; MOLECULAR MECHANICS; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; BCL-X PROTEIN; CARMUSTINE; CASPASE 3; CELL CYCLE; CELL DEATH; CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; DRUG RESISTANCE, NEOPLASM; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOBLASTOMA; HUMANS; LIPOCALINS; LIPOPOLYSACCHARIDES; NITRITES; OLIGONUCLEOTIDES, ANTISENSE; ONCOGENE PROTEIN V-AKT; RATS; TRANSFECTION; VIMENTIN;

RATTUS;

EID: 70350786955     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2009.06410.x     Document Type: Article

References (71)

1. Ali-Osman F., Brunner J. M., Kutluk T. M. Hess K. (1997) Prognostic significance of glutathione S-transferase pi expression and subcellular localization in human gliomas. Clin. Cancer Res. 3, 2253 2261.
2. Baldwin R. M., Garratt-Lalonde M., Parolin D. A., Krzyzanowski P. M., Andrade M. A. Lorimer I. A. (2006) Protection of glioblastoma cells from cisplatin cytotoxicity via protein kinase Ciota-mediated attenuation of p38 MAP kinase signaling. Oncogene 25, 2909 2919.
3. Bartsch S. Tschesche H. (1995) Cloning and expression of human neutrophil lipocalin cDNA derived from bone marrow and ovarian cancer cells. FEBS Lett. 357, 255 259.
4. Bauer M., Eickhoff J. C., Gould M. N., Mundhenke C., Maass N. Friedl A. (2008) Neutrophil gelatinase-associated lipocalin (NGAL) is a predictor of poor prognosis in human primary breast cancer. Breast Cancer Res. Treat. 108, 389 397.
5. Beier D., Hau P., Proescholdt M. et al. (2007) CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res. 67, 4010 4015.
6. Berger T., Togawa A., Duncan G. S., Elia A. J., You-Ten A., Wakeham A., Fong H. E., Cheung C. C. Mak T. W. (2006) Lipocalin 2-deficient mice exhibit increased sensitivity to Escherichia coli infection but not to ischemia-reperfusion injury. Proc. Natl Acad. Sci. USA 103, 1834 1839.
7. Bobola M. S., Berger M. S., Ellenbogen R. G., Roberts T. S., Geyer J. R. Silber J. R. (2001) O6-Methylguanine-DNA methyltransferase in pediatric primary brain tumors: relation to patient and tumor characteristics. Clin. Cancer Res. 7, 613 619.
8. von Bossanyi P., Diete S., Dietzmann K., Warich-Kirches M. Kirches E. (1997) Immunohistochemical expression of P-glycoprotein and glutathione S-transferases in cerebral gliomas and response to chemotherapy. Acta Neuropathol. 94, 605 611.
9. Brahmachari S., Fung Y. K. Pahan K. (2006) Induction of glial fibrillary acidic protein expression in astrocytes by nitric oxide. J. Neurosci. 26, 4930 4939.
10. Bredel M. Zentner J. (2002) Brain-tumour drug resistance: the bare essentials. Lancet Oncol 3, 397 406.
11. Caramuta S., De Cecco L., Reid J. F., Zannini L., Gariboldi M., Kjeldsen L., Pierotti M. A. Delia D. (2006) Regulation of lipocalin-2 gene by the cancer chemopreventive retinoid 4-HPR. Int. J. Cancer 119, 1599 1606.
12. Chakravarti A., Chakladar A., Delaney M. A., Latham D. E. Loeffler J. S. (2002) The epidermal growth factor receptor pathway mediates resistance to sequential administration of radiation and chemotherapy in primary human glioblastoma cells in a RAS-dependent manner. Cancer Res. 62, 4307 4315.
13. Chou T. C. Talalay P. (1984) Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv. Enzyme Regul. 22, 27 55.
14. Cowland J. B., Muta T. Borregaard N. (2006) IL-1beta-specific up-regulation of neutrophil gelatinase-associated lipocalin is controlled by IkappaB-zeta. J. Immunol. 176, 5559 5566.
15. Devireddy L. R., Teodoro J. G., Richard F. A. Green M. R. (2001) Induction of apoptosis by a secreted lipocalin that is transcriptionally regulated by IL-3 deprivation. Science 293, 829 834.
16. Devireddy L. R., Gazin C., Zhu X. Green M. R. (2005) A cell-surface receptor for lipocalin 24p3 selectively mediates apoptosis and iron uptake. Cell 123, 1293 1305.
17. Flo T. H., Smith K. D., Sato S., Rodriguez D. J., Holmes M. A., Strong R. K., Akira S. Aderem A. (2004) Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 432, 917 921.
18. Friedl A., Stoesz S. P., Buckley P. Gould M. N. (1999) Neutrophil gelatinase-associated lipocalin in normal and neoplastic human tissues. Cell type-specific pattern of expression. Histochem. J. 31, 433 441.
19. Furutani M., Arii S., Mizumoto M., Kato M. Imamura M. (1998) Identification of a neutrophil gelatinase-associated lipocalin mRNA in human pancreatic cancers using a modified signal sequence trap method. Cancer Lett. 122, 209 214.
20. Gwira J. A., Wei F., Ishibe S., Ueland J. M., Barasch J. Cantley L. G. (2005) Expression of neutrophil gelatinase-associated lipocalin regulates epithelial morphogenesis in vitro. J. Biol. Chem. 280, 7875 7882.
21. Hanai J., Mammoto T., Seth P., Mori K., Karumanchi S. A., Barasch J. Sukhatme V. P. (2005) Lipocalin 2 diminishes invasiveness and metastasis of Ras-transformed cells. J. Biol. Chem. 280, 13641 13647.
22. Hara A., Sakai N., Yamada H., Niikawa S., Ohno T., Tanaka T. Mori H. (1991) Proliferative assessment of GFAP-positive and GFAP-negative glioma cells by nucleolar organizer region staining. Surg. Neurol. 36, 190 194.
23. Hvidberg V., Jacobsen C., Strong R. K., Cowland J. B., Moestrup S. K. Borregaard N. (2005) The endocytic receptor megalin binds the iron transporting neutrophil-gelatinase-associated lipocalin with high affinity and mediates its cellular uptake. FEBS Lett. 579, 773 777.
24. Iannetti A., Pacifico F., Acquaviva R. et al. (2008) The neutrophil gelatinase-associated lipocalin (NGAL), a NF-kappaB-regulated gene, is a survival factor for thyroid neoplastic cells. Proc. Natl Acad. Sci. USA 105, 14058 14063.
25. Iwadate Y., Fujimoto S., Tagawa M., Namba H., Sueyoshi K., Hirose M. Sakiyama S. (1996) Association of p53 gene mutation with decreased chemosensitivity in human malignant gliomas. Int. J. Cancer 69, 236 240.
26. Jacque C. M., Vinner C., Kujas M., Raoul M., Racadot J. Baumann N. A. (1978) Determination of glial fibrillary acidic protein (GFAP) in human brain tumors. J. Neurol. Sci. 35, 147 155.
27. Klausen P., Niemann C. U., Cowland J. B., Krabbe K. Borregaard N. (2005) On mouse and man: neutrophil gelatinase associated lipocalin is not involved in apoptosis or acute response. Eur. J. Haematol. 75, 332 340.
28. Laine M., Porola P., Udby L. et al. (2007) Low salivary dehydroepiandrosterone and androgen-regulated cysteine-rich secretory protein 3 levels in Sjogren's syndrome. Arthritis Rheum. 56, 2575 2584.
29. Lee J., Hur J., Lee P., Kim J. Y., Cho N., Kim S. Y., Kim H., Lee M. S. Suk K. (2001a) Dual role of inflammatory stimuli in activation-induced cell death of mouse microglial cells. Initiation of two separate apoptotic pathways via induction of interferon regulatory factor-1 and caspase-11. J. Biol. Chem. 276, 32956 32965.
30. Lee P., Lee J., Kim S., Lee M. S., Yagita H., Kim S. Y., Kim H. Suk K. (2001b) NO as an autocrine mediator in the apoptosis of activated microglial cells: correlation between activation and apoptosis of microglial cells. Brain Res. 892, 380 385.
31. Lee H. J., Lee E. K., Lee K. J., Hong S. W., Yoon Y. Kim J. S. (2006) Ectopic expression of neutrophil gelatinase-associated lipocalin suppresses the invasion and liver metastasis of colon cancer cells. Int. J. Cancer 118, 2490 2497.
32. Lee S., Lee J., Kim S., Park J. Y., Lee W. H., Mori K., Kim S. H., Kim I. K. Suk K. (2007) A dual role of lipocalin 2 in the apoptosis and deramification of activated microglia. J. Immunol. 179, 3231 3241.
33. Lee S., Park J. Y., Lee W. H., Kim H., Park H. C., Mori K. Suk K. (2009) Lipocalin-2 is an autocrine mediator of reactive astrocytosis. J. Neurosci. 29, 234 249.
34. Lefranc F., Brotchi J. Kiss R. (2005) Possible future issues in the treatment of glioblastomas: special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis. J. Clin. Oncol. 23, 2411 2422.
35. Li B., Chang C. M., Yuan M., McKenna W. G. Shu H. K. (2003) Resistance to small molecule inhibitors of epidermal growth factor receptor in malignant gliomas. Cancer Res. 63, 7443 7450.
36. Lim R., Ahmed N., Borregaard N., Riley C., Wafai R., Thompson E. W., Quinn M. A. Rice G. E. (2007) Neutrophil gelatinase-associated lipocalin (NGAL) an early-screening biomarker for ovarian cancer: NGAL is associated with epidermal growth factor-induced epithelio-mesenchymal transition. Int. J. Cancer 120, 2426 2434.
37. Lin H. H., Li W. W., Lee Y. C. Chu S. T. (2007) Apoptosis induced by uterine 24p3 protein in endometrial carcinoma cell line. Toxicology 234, 203 215.
38. Liu Q. Nilsen-Hamilton M. (1995) Identification of a new acute phase protein. J. Biol. Chem. 270, 22565 22570.
39. Liu G., Yuan X., Zeng Z. et al. (2006) Analysis of gene expression and chemoresistance of CD133 + cancer stem cells in glioblastoma. Mol. Cancer 5, 67.
40. Lytle R. A., Jiang Z., Zheng X. Rich K. M. (2004) BCNU down-regulates anti-apoptotic proteins bcl-xL and Bcl-2 in association with cell death in oligodendroglioma-derived cells. J. Neurooncol. 68, 233 241.
41. Mandil R., Ashkenazi E., Blass M. et al. (2001) Protein kinase Calpha and protein kinase Cdelta play opposite roles in the proliferation and apoptosis of glioma cells. Cancer Res. 61, 4612 4619.
42. McCormick F. (2004) Cancer: survival pathways meet their end. Nature 428, 267 269.
43. van der Meulen J. D., Houthoff H. J. Ebels E. J. (1978) Glial fibrillary acidic protein in human gliomas. Neuropathol. Appl. Neurobiol. 4, 177 190.
44. Mishra J., Mori K., Ma Q., Kelly C., Yang J., Mitsnefes M., Barasch J. Devarajan P. (2004) Amelioration of ischemic acute renal injury by neutrophil gelatinase-associated lipocalin. J. Am. Soc. Nephrol. 15, 3073 3082.
45. Mori K. Nakao K. (2007) Neutrophil gelatinase-associated lipocalin as the real-time indicator of active kidney damage. Kidney Int. 71, 967 970.
46. Mori K., Lee H. T., Rapoport D. et al. (2005) Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J. Clin. Invest. 115, 610 621.
47. Mueller W., Nutt C. L., Ehrich M., Riemenschneider M. J., von Deimling A., van den Boom D. Louis D. N. (2007) Downregulation of RUNX3 and TES by hypermethylation in glioblastoma. Oncogene 26, 583 593.
48. Nakagawa T., Kubota T., Ido K., Sakuma T. Matsuda K. (2006) Gene expression profiles of 1-(4-amino-2-methyl-5-pyrimidinyl)-methyl-3-(2- chloroethyl)-3-nitrosourea (ACNU)-resistant C6 rat glioma cells. J. Neurooncol. 79, 271 279.
49. Nelson A. M., Zhao W., Gilliland K. L., Zaenglein A. L., Liu W. Thiboutot D. M. (2008) Neutrophil gelatinase-associated lipocalin mediates 13-cis retinoic acid-induced apoptosis of human sebaceous gland cells. J. Clin. Invest. 118, 1468 1478.
50. Nielsen B. S., Borregaard N., Bundgaard J. R., Timshel S., Sehested M. Kjeldsen L. (1996) Induction of NGAL synthesis in epithelial cells of human colorectal neoplasia and inflammatory bowel diseases. Gut 38, 414 420.
51. Nutt C. L., Noble M., Chambers A. F. Cairncross J. G. (2000) Differential expression of drug resistance genes and chemosensitivity in glial cell lineages correlate with differential response of oligodendrogliomas and astrocytomas to chemotherapy. Cancer Res. 60, 4812 4818.
52. Playford R. J., Belo A., Poulsom R. et al. (2006) Effects of mouse and human lipocalin homologues 24p3/lcn2 and neutrophil gelatinase-associated lipocalin on gastrointestinal mucosal integrity and repair. Gastroenterology 131, 809 817.
53. Preuss I., Eberhagen I., Haas S., Eibl R. H., Kaufmann M., von Minckwitz G. Kaina B. (1995) O6-methylguanine-DNA methyltransferase activity in breast and brain tumors. Int. J. Cancer 61, 321 326.
54. Salmaggi A., Boiardi A., Gelati M. et al. (2006) Glioblastoma-derived tumorospheres identify a population of tumor stem-like cells with angiogenic potential and enhanced multidrug resistance phenotype. Glia 54, 850 860.
55. Sarkaria J. N., Kitange G. J., James C. D., Plummer R., Calvert H., Weller M. Wick W. (2008) Mechanisms of chemoresistance to alkylating agents in malignant glioma. Clin. Cancer Res. 14, 2900 2908.
56. Smith E. R., Zurakowski D., Saad A., Scott R. M. Moses M. A. (2008) Urinary biomarkers predict brain tumor presence and response to therapy. Clin. Cancer Res. 14, 2378 2386.
57. Soma M. R., Baetta R., De Renzis M. R. et al. (1995) In vivo enhanced antitumor activity of carmustine [N,N'-bis(2-chloroethyl)-N-nitrosourea] by simvastatin. Cancer Res. 55, 597 602.
58. Sonoda Y., Ozawa T., Aldape K. D., Deen D. F., Berger M. S. Pieper R. O. (2001) Akt pathway activation converts anaplastic astrocytoma to glioblastoma multiforme in a human astrocyte model of glioma. Cancer Res. 61, 6674 6678.
59. Stoesz S. P., Friedl A., Haag J. D., Lindstrom M. J., Clark G. M. Gould M. N. (1998) Heterogeneous expression of the lipocalin NGAL in primary breast cancers. Int. J. Cancer 79, 565 572.
60. Stupp R., Mason W. P., van den Bent M. J. et al. (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med. 352, 987 996.
61. Suk K., Kim S. Y. Kim H. (2002) Essential role of caspase-11 in activation-induced cell death of rat astrocytes. J. Neurochem. 80, 230 238.
62. Tong Z., Wu X. Kehrer J. P. (2003) Increased expression of the lipocalin 24p3 as an apoptotic mechanism for MK886. Biochem. J. 372, 203 210.
63. Tong Z., Wu X., Ovcharenko D., Zhu J., Chen C. S. Kehrer J. P. (2005) Neutrophil gelatinase-associated lipocalin as a survival factor. Biochem. J. 391, 441 448.
64. Tong Z., Kunnumakkara A. B., Wang H. et al. (2008) Neutrophil gelatinase-associated lipocalin: a novel suppressor of invasion and angiogenesis in pancreatic cancer. Cancer Res. 68, 6100 6108.
65. Velasco M. E., Dahl D., Roessmann U. Gambetti P. (1980) Immunohistochemical localization of glial fibrillary acidic protein in human glial neoplasms. Cancer 45, 484 494. (Pubitemid 10169294)
66. Vogelbaum M. A., Tong J. X., Perugu R., Gutmann D. H. Rich K. M. (1999) Overexpression of bax in human glioma cell lines. J. Neurosurg. 91, 483 489.
67. Wolff J. E., Trilling T., Molenkamp G., Egeler R. M. Jurgens H. (1999) Chemosensitivity of glioma cells in vitro: a meta analysis. J. Cancer Res. Clin. Oncol. 125, 481 486.
68. Xu G. W., Mymryk J. S. Cairncross J. G. (2005) Pharmaceutical-mediated inactivation of p53 sensitizes U87MG glioma cells to BCNU and temozolomide. Int. J. Cancer 116, 187 192.
69. Yan L., Borregaard N., Kjeldsen L. Moses M. A. (2001) The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL. J. Biol. Chem. 276, 37258 37265.
70. Yang J., Goetz D., Li J. Y. et al. (2002) An iron delivery pathway mediated by a lipocalin. Mol. Cell 10, 1045 1056.
71. Yuan L., Choi K., Khosla C., Zheng X., Higashikubo R., Chicoine M. R. Rich K. M. (2005) Tissue transglutaminase 2 inhibition promotes cell death and chemosensitivity in glioblastomas. Mol. Cancer Ther. 4, 1293 1302.